For research use only. Not for therapeutic Use.
DDO-2093 dihydrochloride（Cat No.:I042712）is a potent investigational compound primarily being researched for its potential therapeutic effects in oncology. It acts by inhibiting specific molecular targets involved in tumor progression, aiming to disrupt cancer cell proliferation and survival. In preclinical studies, DDO-2093 dihydrochloride has demonstrated promising anti-tumor activity, making it a candidate for further exploration in clinical trials. This compound is being evaluated for its ability to enhance treatment outcomes in various cancer types. Its mechanism of action and safety profile are being closely monitored during ongoing research.
| Synonyms | 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methylpiperazin-1-yl)phenyl]-N-(3-morpholin-4-ylpropyl)triazole-4-carboxamide;dihydrochloride |
| Molecular Formula | C29H39Cl3FN9O3 |
| Purity | ≥95% |
| IUPAC Name | 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methylpiperazin-1-yl)phenyl]-N-(3-morpholin-4-ylpropyl)triazole-4-carboxamide;dihydrochloride |
| InChI | InChI=1S/C29H37ClFN9O3.2ClH/c1-19-26(30)21(17-22(32)27(19)31)28(41)34-23-16-20(4-5-25(23)39-10-8-37(2)9-11-39)40-18-24(35-36-40)29(42)33-6-3-7-38-12-14-43-15-13-38;;/h4-5,16-18H,3,6-15,32H2,1-2H3,(H,33,42)(H,34,41);2*1H |
| InChIKey | RIMZKQNHTPMNER-UHFFFAOYSA-N |
| SMILES | CC1=C(C(=CC(=C1F)N)C(=O)NC2=C(C=CC(=C2)N3C=C(N=N3)C(=O)NCCCN4CCOCC4)N5CCN(CC5)C)Cl.Cl.Cl |
